+61 (02) 9525 3044
Sterile & Cytotoxic Compounding
Bova Expands into the UK
Nick Bova and the team at Bova are proud to announce that they are expanding their Australian operations into the UK. Bova UK has been granted a a license by the Veterinary Medicines Directorate ...
Emma Lagerlow 1:47pm March 29th, 2017
Specials could change the way vets treat horses in the UK
Nick Bova, owner of Bova Australia and now Bova UK, has been granted the first licence in the UK to manufacture sterile specials. The granting of the UK’s first sterile M...
Emma Lagerlow 2:21pm March 17th, 2017
Bova assists surviving patients of poachers in South Africa
Veterinarian, Dr Johan Marais, and his team care for the surviving patients of poachers in South Africa. Recent victims have included: - A rhinoceros bull that was...
Emma Lagerlow 12:42pm January 4th, 2017
Eﬀect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study— A Randomized Clinical Trial
This study evaluates the effect of pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly. Click here to be directed to the full study in the Journal if Veterina...
Emma Lagerlow 9:15am December 9th, 2016
ACVIM Small Animal Consensus Recommendations on the Treatment and Prevention of Uroliths in Dogs and Cats
In an age of advancing endoscopic and lithotripsy technologies, the management of urolithiasis poses a unique opportunity to advance compassionate veterinary care, not only for patients with uroli...
Emma Lagerlow 2:48pm December 8th, 2016